Muthu Meyyappan

Muthu Meyyappan serves as the Global Chief Commercial Officer at Menarini Silicon Biosystems since May 2022, focusing on transforming the Oncology business unit's commercial strategy and enhancing the adoption of the FDA-approved CellSearch® liquid biopsy test. Previously, Muthu held the position of Chief Commercial Officer at Congenica, driving global sales and marketing for a CE-IVD NGS SaaS platform, and at Variantyx, leading the commercial launch of whole genome testing services. Muthu has also held various leadership roles at QIAGEN, including Vice President of Advanced Genomics Commercial Operations, where significant revenue growth was achieved, and at BIOBASE Corporation, where a commercial operations organization was established. Early career roles included positions at Incyte Corporation and Wyeth-Ayerst Research, underscoring a strong background in life sciences and biotechnology, supported by a Ph.D. in Cancer Biology from the University of Calgary and a B.S. in Biotechnology from the Rochester Institute of Technology.